Article Versions Notes

Taylor C, Patterson KM, Friedman D, Bacot SM, Feldman GM, Wang T. Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer. Cancers. 2024; 16(17):3071. https://doi.org/10.3390/cancers16173071

Taylor, Caroline, Kamai M. Patterson, Devira Friedman, Silvia M. Bacot, Gerald M. Feldman, and Tao Wang. 2024. "Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer" Cancers 16, no. 17: 3071. https://doi.org/10.3390/cancers16173071

Taylor, C., Patterson, K. M., Friedman, D., Bacot, S. M., Feldman, G. M., & Wang, T. (2024). Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer. Cancers, 16(17), 3071. https://doi.org/10.3390/cancers16173071